169 related articles for article (PubMed ID: 4629882)
41. Experimental subarachnoid hemorrhage: a study for spasm with the production of aneurysms.
Roy VC; Sundt TM; Murphey F
Stroke; 1970; 1(4):248-52. PubMed ID: 5001803
[No Abstract] [Full Text] [Related]
42. Regional cerebral oxygen saturation during intra-arterial papaverine therapy for vasospasm: case report.
Luer MS; Dujovny M; Slavin KV; Hernandez-Avila G; Ausman JI
Neurosurgery; 1995 May; 36(5):1033-6. PubMed ID: 7791970
[TBL] [Abstract][Full Text] [Related]
43. Intraarterial infusion of papaverine in experimental cerebral vasospasm.
Fujiwara N; Honjo Y; Ohkawa M; Tanabe M; Irie K; Nagao S; Takashima H; Satoh K; Kojima K
AJNR Am J Neuroradiol; 1997 Feb; 18(2):255-62. PubMed ID: 9111660
[TBL] [Abstract][Full Text] [Related]
44. Reversal of experimental delayed cerebral vasospasm by angiotensin-converting enzyme inhibition.
Gavras H; Andrews P; Papadakis N
J Neurosurg; 1981 Dec; 55(6):884-8. PubMed ID: 6170740
[TBL] [Abstract][Full Text] [Related]
45. Effect of high-dose methylprednisolone on vasospasm after subarachnoid hemorrhage.
Yamakawa K; Sasaki T; Tsubaki S; Nakagomi T; Saito I; Takakura K
Neurol Med Chir (Tokyo); 1991 Jan; 31(1):24-31. PubMed ID: 1712919
[TBL] [Abstract][Full Text] [Related]
46. Intra-arterial papaverine treatment for cerebral vasospasm: our experience and review of the literature.
Numaguchi Y; Zoarski GH
Neurol Med Chir (Tokyo); 1998 Apr; 38(4):189-95. PubMed ID: 9631632
[TBL] [Abstract][Full Text] [Related]
47. Etiology and treatment of vasospasm following subarachnoid hemorrhage.
Nonaka T; Watanabe S; Chigasaki H; Miyaoka M; Ishii S
Neurol Med Chir (Tokyo); 1979 Jan; 19(1):53-60. PubMed ID: 84356
[No Abstract] [Full Text] [Related]
48. Effect of intrathecal superoxide dismutase and catalase on oxyhemoglobin-induced vasospasm in monkeys.
Macdonald RL; Weir BK; Runzer TD; Grace MG; Poznansky MJ
Neurosurgery; 1992 Apr; 30(4):529-39. PubMed ID: 1584351
[TBL] [Abstract][Full Text] [Related]
49. [Cerebral vasospasm in primary subarachnoid hemorrhage].
Kadanka Z; Hrazdira CL; Novotný O; Pellar M
Cesk Neurol Neurochir; 1984 Jan; 47(1):16-9. PubMed ID: 6713565
[No Abstract] [Full Text] [Related]
50. Improvement of cerebral oxygenation patterns and metabolic validation of superselective intraarterial infusion of papaverine for the treatment of cerebral vasospasm.
Fandino J; Kaku Y; Schuknecht B; Valavanis A; Yonekawa Y
J Neurosurg; 1998 Jul; 89(1):93-100. PubMed ID: 9647178
[TBL] [Abstract][Full Text] [Related]
51. Intracranial pressure monitoring during intraarterial papaverine infusion for cerebral vasospasm.
Cross DT; Moran CJ; Angtuaco EE; Milburn JM; Diringer MN; Dacey RG
AJNR Am J Neuroradiol; 1998 Aug; 19(7):1319-23. PubMed ID: 9726476
[TBL] [Abstract][Full Text] [Related]
52. [Effect of calcitonin gene-related peptide and vasoactive intestinal polypeptide on delayed cerebral vasospasm studied after experimental subarachnoid hemorrhage in rabbits].
Shimizu H; Imaizumi S; Ishtiaq A; Kaminuma T; Tajima M; Yoshimoto T
No Shinkei Geka; 1994 Feb; 22(2):131-9. PubMed ID: 8115007
[TBL] [Abstract][Full Text] [Related]
53. Effectiveness of intra-arterially infused papaverine solutions of various concentrations for the treatment of cerebral vasospasm.
Sawada M; Hashimoto N; Tsukahara T; Nishi S; Kaku Y; Yoshimura S
Acta Neurochir (Wien); 1997; 139(8):706-11. PubMed ID: 9309284
[TBL] [Abstract][Full Text] [Related]
54. Spasmolytic effect of acidic fibroblast growth factor in early cerebral vasospasm in the rat.
Cuevas P; Carceller F; Nieto I; Giménez-Gallego G
Surg Neurol; 1998 Feb; 49(2):176-9; discussion 179-80. PubMed ID: 9457268
[TBL] [Abstract][Full Text] [Related]
55. [Clinical analysis of cerebral vasospasm following subarachnoid hemorrhage -- aging and cerebral vasospasm (author's transl)].
Koike T; Ishii R; Ihara I; Kameyama S; Takeuchi S; Kobayashi K
No To Shinkei; 1981 May; 33(5):499-504. PubMed ID: 7259909
[No Abstract] [Full Text] [Related]
56. Etiology of cerebral vasospasm in primates.
Macdonald RL; Weir BK; Runzer TD; Grace MG; Findlay JM; Saito K; Cook DA; Mielke BW; Kanamaru K
J Neurosurg; 1991 Sep; 75(3):415-24. PubMed ID: 1869943
[TBL] [Abstract][Full Text] [Related]
57. Alacepril, an angiotensin-converting enzyme inhibitor, prevents cerebral vasospasm in subarachnoid hemorrhage model in rats.
Honda Y; Minato H; Fujitani B; Masuda Y; Hosoki K
Methods Find Exp Clin Pharmacol; 1997 Dec; 19(10):699-706. PubMed ID: 9542720
[TBL] [Abstract][Full Text] [Related]
58. [Experimental cerebral arterial spasm and its relations to spontaneous pathology in humans].
Fortuna A; La Torre E
Riv Neurol; 1970; 40(6):386-423. PubMed ID: 5519837
[No Abstract] [Full Text] [Related]
59. Attenuation of basilar artery spasm after experimental subarachnoid hemorrhage in rabbit by potassium channel activator cromakalim--a preliminary result.
Kwan AL; Lin CL; Howng SL
Kaohsiung J Med Sci; 1999 May; 15(5):268-73. PubMed ID: 10375869
[TBL] [Abstract][Full Text] [Related]
60. [An experimental study on intrathecal injection of fibrinolytic agent for angiospasm following subarachnoid hemorrhage in the dogs (author's transl)].
Yoshida Y; Handa H; Hayashi T; Amo M; Aoki M; Kusuno K; Lee E; Uno T
Nihon Geka Hokan; 1979 Mar; 48(2):188-96. PubMed ID: 162263
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
